These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1021 related articles for article (PubMed ID: 12866309)

  • 1. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 5. Letters on management of ischemic stroke.
    Porat G
    Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038
    [No Abstract]   [Full Text] [Related]  

  • 6. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical potential of low molecular weight heparins.
    Messmore HL
    Semin Thromb Hemost; 1989 Oct; 15(4):405-8. PubMed ID: 2554501
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of venous thromboembolism: optimization by clinical trials.
    Turpie AG
    Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
    Kakkar VV
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 12. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Penner J
    N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 14. Practice tips. Deep venous thrombosis: before and after. Improving diagnosis and adjusting duration of therapy.
    Greiver M
    Can Fam Physician; 2000 Apr; 46():813-5. PubMed ID: 10790813
    [No Abstract]   [Full Text] [Related]  

  • 15. ["How must deep leg venous thrombosis be diagnosed and treated?"].
    Bruhn HD
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1730-1. PubMed ID: 12920673
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulant treatment in deep venous thrombosis].
    Navarro JL
    Sangre (Barc); 1993 Apr; 38(2):125-30. PubMed ID: 8390725
    [No Abstract]   [Full Text] [Related]  

  • 17. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Strandness DE
    N Engl J Med; 1996 Aug; 335(9):670-1; author reply 671-2. PubMed ID: 8692246
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
    Diener HC
    MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism.
    Goldhaber SZ; Fanikos J
    Circulation; 2004 Oct; 110(16):e445-7. PubMed ID: 15492324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 52.